| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-06 |
| mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
5e-05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
6e-05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
6e-05 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0001 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |